Stem cell preparation system close to approval in US
This article was originally published in Clinica
Nexell Therapeutics' Isolex stem cell preparation system, is close to gaining FDA approval for use as an adjunct to cancer chemotherapy. The Irvine, California-based company says that it has received an approvable letter from the FDA for its Isolex 300 and automated Isolex 300i Cell Selection Systems, which are used to purify cells in bone marrow and peripheral blood transplantation.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.